ctl immunospot s6 core versa micro uv analyzer (Cellular Technology Ltd)
99
Structured Review
Cellular Technology Ltd
ctl immunospot s6 core versa micro uv analyzer
Ctl Immunospot S6 Core Versa Micro Uv Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2104 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ctl-immunospot+s6+core+analyzer/ImmunoSpot+Software/pm41621381-127-10-17
Average 99 stars, based on 2104 article reviews
Ctl Immunospot S6 Core Versa Micro Uv Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 2104 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ctl-immunospot+s6+core+analyzer/ImmunoSpot+Software/pm41621381-127-10-17
Average 99 stars, based on 2104 article reviews
ctl immunospot s6 core versa micro uv analyzer - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Enzyme-linked Immunospot:Article Title: Tumor-reprogrammed resident T cells resist radiation to control tumors Article Snippet: Spots were developed by the addition of AEC substrate (all ELISPOT reagents from BD Pharmingen) and quantitated using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: Plates were then captured and counted using a Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Article Snippet: Plates were captured and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma. Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: The plates were read and analyzed on Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia Article Snippet: Plates were captured and counted using a Incubation:Article Title: Tumor-reprogrammed resident T cells resist radiation to control tumors Article Snippet: Spots were developed by the addition of AEC substrate (all ELISPOT reagents from BD Pharmingen) and quantitated using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: Plates were then captured and counted using a Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Article Snippet: Plates were captured and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma. Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: The plates were read and analyzed on Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia Article Snippet: Plates were captured and counted using a Labeling:Article Title: Tumor-reprogrammed resident T cells resist radiation to control tumors Article Snippet: Spots were developed by the addition of AEC substrate (all ELISPOT reagents from BD Pharmingen) and quantitated using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: Plates were then captured and counted using a Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Article Snippet: Plates were captured and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma. Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma Article Snippet: The plate was then air-dried, captured, and counted using a Article Title: Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial Article Snippet: The plates were read and analyzed on Article Title: WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia Article Snippet: Plates were captured and counted using a |